Tumour-associated peptides binding to mhc-molecules

Details Tumour-associated peptides binding to mhc-molecules Tumour-associated peptides binding to mhc-molecules

C - Chemistry, Metallurgy

07

K

C07K 14/47 (2006.01) A61K 38/08 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01) A61P 37/04 (2006.01) C07K 7/06 (2006.01) C07K 7/08 (2006.01) C12N 15/12 (2006.01) G01N 33/68 (2006.01) C07K 14/74 (2006.01)

Patent

CA 2731275

The invention relates to a tumour-associated peptide having an amino acid sequence selected from the group consisting of SEQ ID No. 1 to SEQ ID No. 101 from the associated sequence protocol, said peptide being able to bind to a molecule of the human major histocompatibility complex (MHC) class I. The invention also relates to the use of said peptides and the nucleic acids coding therefor, for producing a medicament and for the treatment of tumour diseases and/or adenomatous diseases. The invention further relates to a pharmaceutical composition comprising at least one of said peptides.

Affiliated with

Also associated with

Rating

Tumour-associated peptides binding to mhc-molecules does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tumour-associated peptides binding to mhc-molecules, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumour-associated peptides binding to mhc-molecules will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2024194